A manufacturer program operator shall maintain records for 5 years of any changes to an approved drug take-back program. These include, but are not limited to, changes in:
         (1) participating covered manufacturers;
         (2) collection methods;
         (3) collection site locations; or
         (4) contact information for the program operator or
    
authorized collectors.